Physician profile
Kathleen C Mitchell
NPI 1528043841
$1,525.76
in general payments reported to CMS, 2019-2025
23 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $73.51 · 2021: $253 · 2022: $323 · 2023: $202 · 2024: $163 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $667.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $216.20 | 2021-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $199.17 | 2019-2023 | |
| Sage Therapeutics, LLC | $192.26 | 2024-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $137.88 | 2019-2022 | |
| Exeltis, USA INC. | $96.37 | 2020-2023 | Slynd |
| Mayne Pharma Commercial LLC | $85.98 | 2022-2025 | |
| Pfizer INC. | $82.48 | 2023-2025 | |
| Myovant Sciences INC. | $72.78 | 2021-2022 | |
| Avion Pharmaceuticals | $69.04 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.30 | 2019-2025 | |
| Daiichi Sankyo INC. | $43.79 | 2021-2022 | |
| Shield Therapeutics INC | $35.76 | 2023 | Accrufer |
| Allergan, INC. | $34.75 | 2019 | |
| Coopersurgical, INC. | $33.11 | 2021-2022 | |
| Urovant Sciences INC | $28.76 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $24.50 | 2019-2022 | |
| Millicent US INC | $22.03 | 2025 | Intrarosa |
| Supernus Pharmaceuticals, INC. | $20.00 | 2025 | Qelbree |
| Sumitomo Pharma America, INC. | $18.50 | 2023 | Myfembree |
| Roche Diagnostics Corporation | $16.45 | 2021 | |
| Organon LLC | $12.95 | 2022 | |
| Evofem Biosciences, INC. | $12.08 | 2021 | |
| Amag Pharmaceuticals, INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.